News Direct

Category: News

  • Building Tomorrow’s Workforce: CoorsTek Launches Advanced Manufacturing Academy in Colorado

    News release by CoorsTek

    Building Tomorrow’s Workforce: CoorsTek Launches Advanced Manufacturing Academy in Colorado

    Golden, CO — July 17, 2025 — 9:00 AM Mountain Standard Time – CoorsTek, a leading global manufacturer of technical ceramics, proudly marked the official opening of its state-of-the-art CoorsTek Academy Training Center with a ribbon cutting ceremony held on Wednesday, July 16. The event brought together company leadership, state officials, and industry and education partners to celebrate a major milestone in advancing Colorado’s advanced manufacturing workforce.

    Made possible in part by the State of Colorado’s Opportunity Now grant, the Academy is designed to prepare and upskill the next generation of manufacturing talent. The center will provide immersive, hands-on learning for individuals pursuing careers in advanced manufacturing—an industry that plays a vital role in Colorado’s economic future.

    “The opening of the CoorsTek Academy Training Center is the realization of a bold vision to shape the future of advanced manufacturing in Colorado,” said Irma Lockridge, Chief People and Systems Officer at CoorsTek. “This facility reflects our commitment to developing talent, fostering innovation, and investing in the people who will lead this industry forward. It’s more than a training center—it’s a launchpad for meaningful careers and long-term impact.”

    The Academy is equipped with the latest manufacturing equipment, offering participants a real-world experience as well as curriculum aligned to industry demand. In addition there will be apprenticeship programs in maintenance and tool and die and certification in CNC and advanced manufacturing in partnership with our educational institutions. 

    Governor Jared Polis, who provided remarks during the ceremony, emphasized the importance of initiatives like the CoorsTek Academy in addressing workforce needs: “In Colorado, we are growing a strong workforce today, to fill the jobs of tomorrow. Colorado’s advanced manufacturing industry includes over 6,300 companies that employ over 150,000 workers. And as the industry continues to grow, so too will the demand for workers with the skills needed to drive growth and innovation, helping students gain the necessary skills to succeed and fill in-demand jobs.”

    About CoorsTek
    Founded in 1910, CoorsTek is a leading global manufacturer of technical ceramics. By leveraging expertise in engineering and materials science, CoorsTek provides solutions to complex technical challenges in the semiconductormedicalautomotiveaerospace, and other industries. With over 400 proprietary formulations, vertically integrated systems, and unparalleled process capabilities, CoorsTek partners with its customers to make the world measurably better.

     

    For media inquiries, please contact:

     

    Nancy Fullerton

    Sr. Communications Director

    517-304-4695/nfullerton@coorstek.com

  • G6 Hospitality Launches 24/7 Customer Support to Enhance Guest Experience 

    News release by G6 Hospitality

    G6 Hospitality Launches 24/7 Customer Support to Enhance Guest Experience 

    DALLAS, TX– July 16, 2025 – 9:00 AM Eastern Time – G6 Hospitality, parent company of Motel 6 and Studio 6, today announced the launch of its new 24×7 customer support service exclusively for guests, effective August 1, 2025. This service expands the previous 18-hour support window to round-the-clock availability via phone, email, and social media channels, ensuring guests receive timely assistance whenever they need it.

    Guests with urgent (SOS) queries can reach the dedicated support team at any time by calling 1-800-557-3435 emailing Guestrelations@g6reservations.com and direct messaging through G6’s official social media channels. All escalations from phone, email, and social media tagging will be addressed promptly by trained customer service professionals.

    This enhancement comes as G6 Hospitality is already in the midst of the busy summer and peak travel season. This is an effort to provide reliable guest support during periods of high demand.

    “Extending our customer support to operate 24 hours a day, seven days a week allows us to provide assistance to guests whenever needed, particularly during the current peak travel season. This service is specifically designed to support guests throughout their stay.” said Sonal Sinha, CEO of G6 Hospitality.

    The 24×7 guest support service complements G6 Hospitality’s ongoing investments in technology and service innovation. The company recently launched its AI-powered My6 app, which delivers a faster, more personalized booking experience and has already driven a 14% year-over-year increase in direct bookings.

    About G6 Hospitality LLC:

    G6 Hospitality LLC is the leading economy lodging franchisor, with nearly 1,500 economy lodging locations under the iconic Motel 6 and Studio 6 brands in the United States and Canada. G6 Hospitality is committed to making hospitality accessible to all through responsible business practices and unparalleled opportunity for franchisees to build a legacy through ownership. Both Motel 6 and Studio 6 were recognized in the 2024 Entrepreneur Franchise 500® report, with Motel 6 ranking in the top 50 of all franchises. The Carrollton, Texas-based company was named a 2024 Leader in Diversity by Dallas Business Journal. For more information, please visit www.g6hospitality.com

    Press Contact:
    Anupriya Malik
    anupriya.d@g6hospitality.com

  • BioLumic Brings Food-System Pioneers to Scientific Advisory Group, Deepening World-Class Expertise in Light-Programmed Seed Traits

    News release by Biolumic

    BioLumic Brings Food-System Pioneers to Scientific Advisory Group, Deepening World-Class Expertise in Light-Programmed Seed Traits

    Dr. Howard-Yana Shapiro and Prof. Jeremy Hill join Prof. Mark Tester and Dr. John Bedbrook to guide real-world deployment of BioLumic’s xTraitsTM platform

    CHAMPAIGN, Illinois – July 15, 2025 9:00 AM Eastern Time – BioLumic, the only agricultural biotechnology company that programs seed traits using light, today announced the appointment of Dr. Howard-Yana Shapiro, distinguished senior fellow at CIFOR-ICRAF, and Dr. Jeremy Hill, chief science & technology officer at Fonterra Co-operative Group Limited, to its Scientific Advisory Group.

    Dr. Shapiro and Professor Hill join founding members Professor Mark Tester – internationally renowned for pioneering the science of salt-tolerant crops – and Dr. John Bedbrook, former DuPont Vice President and inventor on more than 50 plant-biotech patents. Together, the four advisors bring a uniquely diverse mix of agronomic and biotechnology discovery for world-leading innovations.

    “Bringing on Howard and Jeremy strengthens an advisory team with a proven track record of scaling breakthrough science from lab bench to global impact,” said Steve Sibulkin, CEO of BioLumic. “Their insights will accelerate the impact of our light-signal xTraits™ platform, helping ensure it delivers meaningful value for farmers, industry, and the planet—while advancing a more resilient food system.” 

    BioLumic’s patented xTraits™ platform delivers precisely timed UV-light signals to activate plants’ own gene-expression pathways. The result is double-digit gains in yield, quality, and resilience in a fraction of the time and cost of conventional trait development, and all without altering DNA. Advanced programs in corn, soybeans, rice, and forage crops are already under way with multiple partners, including food production companies, charitable entities, and leading seed companies.

    New Scientific Advisory Group Members:

    Dr. Howard-Yana Shapiro is a 50-year crop-science pioneer who led global agriculture initiatives at Mars, Inc., and founded the African Orphan Crops Consortium, which is working to improve 101 nutrient-dense crops critical to food security across Africa. He has driven scientific efforts that combine biodiversity, nutrition, and equitable access to high-performing crops. 

    “I am excited to support BioLumic’s pioneering work in using light to naturally enhance plant performance,” said Shapiro. “Harnessing the power of biology and light opens up powerful new pathways for crop productivity and resilience traits.”

    Professor Jeremy Hill brings decades of experience in science, technology, nutrition and sustainability across the entire farm-to-consumer dairy value chain. As Fonterra’s Chief Science & Technology Officer, and former President of the International Dairy Federation, he helped lead the development of international greenhouse gas and nutrition frameworks for agriculture and food systems. In 2020, Prof. Hill was awarded the Member of the New Zealand Order of Merit for services to the dairy industry and scientific research in the Queen’s Birthday Honours. 

    “BioLumic’s innovation sits at the nexus of science, sustainability, and food system transformation,” said Hill. “I look forward to contributing to BioLumic’s efforts to shape the future of sustainable agriculture.”

    BioLumic’s Scientific Advisory Group brings deep expertise across plant science, trait commercialization, global food systems, and sustainability.

    About BioLumic
    Founded in 2013, BioLumic is a U.S.- and New Zealand-based agricultural biotechnology company using light signaling as a programming language for plants. Its patented xTraits™ technology unlocks non-GMO genetic expression traits to enhance yield, composition, and crop resilience through a one-time, light-based seed application. BioLumic traits are scalable, fast to develop, and easily integrated into existing seed systems. Learn more at www.biolumic.com or contact info@biolumic.com.

    Contact

    AgTech PR for BioLumic

    Jennifer Godston

    jennifer@agtechpr.com

     

     

  • OREGON CITY WELCOMES FIRST XFINITY STORE

    OREGON CITY WELCOMES FIRST XFINITY STORE

    News release by COMCAST

    Oregon City, OR – July 11, 2025 — 2:05 PM Eastern Time – Comcast has officially opened the doors to its first Xfinity Store in
    Oregon City, offering residents a new, convenient location to explore the latest in internet, mobile, TV, and
    home security services. Located at 1420 Molalla Ave., Oregon City, OR 97045, the nearly 1,900-square-foot
    store is designed to enhance the customer experience with hands-on product demonstrations, personalized
    support, and a welcoming environment.

    The new store enhances the existing availability of Xfinity services in the area by providing a local destination
    for customers to manage their accounts, receive technical assistance, and learn more about the company’s
    offerings—all without leaving town. The store is open Monday through Saturday from 10 a.m. to 7 p.m. and
    Sunday from 11 a.m. to 6 p.m. Trained specialists are available to assist with service upgrades, troubleshooting,
    and product education.

    “We’re excited to be part of the Oregon City community in a more personal way,” said Israel Velazquez, store
    manager. “This store gives our customers a place to connect with our team face-to-face, ask questions, and
    discover how Xfinity can support their digital lifestyles. We’re here to make technology simple and accessible.”

    This opening is part of Comcast’s broader effort to invest in local communities and improve the accessibility of
    its services through neighborhood-based retail locations. For more information about Xfinity products and
    services, visit www.xfinity.com.

    About Comcast Corporation
    Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and
    platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of
    customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through
    Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news
    through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and
    attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more
    information.

    # # #

    Media Contact
    Rachael Arnold, External Communications Manager
    Rachael_Arnold@Comcast.com

  • MedCognetics Introduces the First Embedded AI Cancer Detection System for Mammography Imaging

    News release by MedCognetics

    MedCognetics Introduces the First Embedded AI Cancer Detection System for Mammography Imaging

    DALLAS, TX – October 10, 2024  – 7:24 AM Eastern Time  MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography. The system utilizes the NVIDIA IGX OrinTM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse global dataset to enhance the performance of radiologists and help improve patient outcomes worldwide.

    Incorporating MedCognetics’ new system would allow for AI-driven image enhancement and cancer detection to occur in real-time within the mammography device itself. The embedded solution eliminates latency, delivering immediate, high-quality image analysis, a significant improvement over traditional setups that require external workstations or cloud-based processing. This approach is poised to improve patient outcomes through faster results, enhanced image quality and reduced hardware costs.

    “Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.”

    The NVIDIA IGX Orin platform combines enterprise-level hardware, software, and support. It is purpose-built for industrial and medical edge computing. The platform delivers the performance, durability, security, and safety required for advanced AI applications and features programmable safety extensions, commercial OS support, and powerful AI software. These capabilities, equip organizations to confidently deploy AI safely and securely for enhanced human and machine collaboration.

    The embedded AI system developed by MedCognetics offers several key benefits:

    1. On-Premises Device: Rapid, complete analysis right in the radiology workflow.
    2. Enhanced Image Quality: AI-driven enhancements improve the clarity and detail of images without requiring high-end, expensive hardware.
    3. Immediate Results: Processing occurs within the device, providing instant analysis and reducing the wait time for results.
    4. Cost Efficiency: Medical device manufacturers can achieve high-end image quality at a fraction of the cost by utilizing AI rather than upgrading hardware.
    5. Workflow Optimization: Enables worklist prioritization and clinic-determined workflow optimization, enhancing the accuracy and efficiency of radiologists and imaging centers.
    6. Easy Upgrades and Maintenance: Software-based solutions are easier to update and maintain, helping to ensure that medical imaging equipment remains cutting-edge without frequent hardware replacements.

    Earlier this year, MedCognetics was awarded a groundbreaking patent by the United States Patent and Trademark Office (USPTO) for its inclusive, unbiased medical imaging AI technology in mammography. Its expertise in embedded engineering, combined with the NVIDIA IGX platform, is poised to significantly advance medical imaging technology. This work underscores the importance of integrating AI into medical devices to enhance diagnostic capabilities and patient care.

    For more information about this new embedded AI cancer detection system, visit here.

    About CogNet AI-MT®

    CogNet AI-MT is part of MedCognetics’ comprehensive CogNet AI™ platform, designed to enhance radiologists’ capabilities by expanding insights and awareness in medical imaging. This unbiased platform, trained on a diverse global dataset, advances the performance of radiologists and imaging centers, delivering accurate care for patients worldwide. CogNet AI-MT employs advanced AI and Machine Learning (ML) to detect early signs of cancer across all ethnicities and can be deployed on customer premises, in the cloud, or via the web. The platform is FDA 510(k) cleared for triage of mammogram images.

    Useful Links:

    Learn More: www.medcognetics.com

    Follow us: X | LinkedIn

    Sales and Partnership Inquiries:

    Please contact MedCognetics, Inc. at: media@medcognetics.com

    About MedCognetics, Inc.

    MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com.

     

    # # #

  • MedCognetics Secures Groundbreaking Patent for Inclusive, Unbiased Medical Imaging AI Technology in Mammography

    MedCognetics Secures Groundbreaking Patent for Inclusive, Unbiased Medical Imaging AI Technology in Mammography

    News release by MedCognetics

    DALLAS, TX – APRIL 4, 2024 – 11:48 AM Eastern Time – 

    In a significant stride towards equitable healthcare technology, MedCognetics, Inc., a company focusing on medical imaging AI, today announced it has been awarded patent number 11,948,297 by the United States Patent and Trademark Office (USPTO).

    The patent covers architectural strategies and methodologies for achieving unbiased AI in breast imaging. This innovation is backed by MedCognetics’ peer-reviewed publications in industry conferences such as the Radiological Society North America (RSNA) 2023, the European Society of Radiology (ESR) 2024, and a grant from the National Institutes of Health (NIH). This breakthrough is set to redefine the development of AI in the medical field ensuring MedCognetics’ algorithms maintain high performance across different patient demographics, thereby guaranteeing consistent, fair, superior patient outcomes.

    “This patent is a reflection of our team’s focused pursuit of innovation and commitment to inclusivity,” said Ron Nag, CEO of MedCognetics, Inc. “Our technology is not just about improving patient outcomes through earlier and more accurate diagnoses; the focus is on fostering equality in technological development and ensuring universal access to advancements in healthcare systems worldwide. We remain dedicated to progressing in the field of unbiased medical imaging technology.”

    MedCognetics is actively engaged in partnerships with leading healthcare institutions and research organizations to bring its patented AI technology into clinical practice, aiming for widespread patient benefit from these advancements at the earliest.

    Full details of the allowance are listed in the Issue Notification Certificate issued by the USPTO. For further information about MedCognetics and its pioneering medical imaging AI technology, please visit www.medcognetics.com.

    About MedCognetics, Inc.

    MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com.

    Contact Details

    ANW Networks

    Alicia Nieva-Woodgate

    +1 415-515-0866

    alicia@anwnetworks.com

    Company Website

    https://www.medcognetics.com

  • YWCA and Comcast Partner for Mayor Harrell’s 4th Annual One Seattle Day of Service

    YWCA and Comcast Partner for Mayor Harrell’s 4th Annual One Seattle Day of Service

    SEATTLE, WA – July 14, 202511:05 PM Pacific Time – As a part of Mayor Bruce Harrell’s 4th Annual One Seattle Day of Service, YWCA Seattle | King | Snohomish partnered with Comcast last weekend to support women and families facing food and housing instability. On Saturday, July 12, Comcast employees volunteered at the YWCA Phillis Wheatley Branch. They worked on various projects, including preparing back-to-school backpacks, creating welcome home kits, assembling food bank bags, refreshing paint, and organizing storage.

    Volunteers were surprised and honored by a visit from Mayor Bruce Harrell. He stopped by to thank Comcast employees and YWCA staff for their service. His visit underscored the spirit of unity and civic pride that defines the One Seattle Day of Service. 

    “With the 2026 World Cup on the horizon, Seattle has a once-in-a-generation opportunity to show the world who we are – a city united by compassion, inclusion, bold action, and a deep commitment to each other,” said Mayor Harrell. “I was proud to join together with partners like YWCA and Comcast on the One Seattle Day of Service to showcase our values, give back to our city, and build stronger communities.”

    This year’s Day of Service featured more than 2,500 volunteer shifts across over 85 events citywide. It brought together neighbors, businesses, and nonprofits to beautify neighborhoods, restore green spaces, and support vulnerable communities. The YWCA and Comcast collaboration was one of many efforts showcasing the power of collective action to build a stronger, more connected Seattle.

    “YWCA was honored to participate in Mayor Bruce Harrell’s One Seattle Day of Service and thrilled to deepen our partnership with Comcast,” said Maria Chavez-Wilcox, YWCA Seattle | King | Snohomish chief executive officer. “Volunteers are a critical part of our legacy of providing services to women, children, and families throughout our community for over 130 years. Together we honor our history, navigate the challenges of our current times, and pave the way for future generations.”

    “At Comcast, we believe in the power of community and the responsibility we share to uplift one another. Partnering with YWCA for the One Seattle Day of Service is a meaningful way for our employees to give back, supporting women and families facing food and housing insecurity,” said Marianne Bichsel, Comcast External Affairs vice president. “Whether it’s assembling backpacks or refreshing community spaces, our team is proud to stand alongside YWCA and support Mayor Harrell in building a stronger, more connected Seattle.”

    Founded in 1919 to serve the growing African American community in Seattle’s Central Area, the Phillis Wheatley Branch now provides emergency housing and operates the Central Area Food Bank. In 2024, the food bank distributed 347,887 pounds of food to an average of 330 households each week.

    About YWCA Seattle | King | Snohomish:

    Founded over 130 years ago, YWCA Seattle | King | Snohomish is the largest and longest-running nonprofit in the region dedicated to the needs of women and girls. Through direct services and advocacy, YWCA works to promote justice and opportunity in housing, economic advancement, health, and safety, with programs that serve 9,000 women, men, and children in King County and Snohomish County annually. YWCA is dedicated to promoting peace, justice, freedom, and dignity for all. Visit our website to learn more at www.ywcaworks.org.

    About Comcast Corporation

    Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more information.

     

    #  #  #

  • OS Therapies Inc. (NYSE-A: OSTX) Makes Important Strides in Rare Cancer Therapy

    OS Therapies Inc. (NYSE-A: OSTX) Makes Important Strides in Rare Cancer Therapy

    NAPLES, FL – July 12, 2025 – 7:00 AM Eastern Time – The global oncology drug market is currently valued at over 200 billion dollars and is expected to more than double to 532 billion dollars by 2031. This growth is driven not only by rising demand but also by genuine innovation. After years of steady but incremental progress, newer therapies such as antibody drug conjugates and immunotherapies are making real headway against some of oncology’s toughest challenges, including rare pediatric cancers, relapsed tumors, and diseases like osteosarcoma, where survival rates have remained largely stagnant.

    Regulatory agencies are accelerating these advances with tools like Fast Track and Accelerated Approval. At the same time, comparative oncology, which leverages naturally occurring canine cancers to generate more clinically relevant data, is creating fresh opportunities for development. This convergence makes the current moment especially promising for investors focused on oncology innovation.

    One company leading in this space is OS Therapies (NYSE-A: OSTX), a clinical-stage biopharmaceutical firm advancing immunotherapies and precision oncology platforms. Its lead candidate, OST HER2, has shown statistically significant survival benefits in patients with recurrent fully resected lung metastatic osteosarcoma, a population with very limited treatment options and poor historical outcomes. With regulatory engagement progressing in both the United States and Europe, OSTX could be poised for a potential breakout.

    Breakthrough Potential in Osteosarcoma

    OS Therapies (NYSE-A: OSTX) is advancing OST-HER2, a novel immunotherapy designed to activate the immune system against HER2-expressing cancer cells using a bioengineered form of Listeria monocytogenes. The company recently released compelling Phase 2b data for patients with recurrent, fully resected lung metastatic osteosarcoma, a population with limited options and poor historical outcomes.

    Among the 40 patients treated with OST-HER2, 35 percent achieved one-year event-free survival, compared with 20 percent in a peer-reviewed historical control group. The p-value of 0.0194 suggests the result is statistically significant. Just as important, no patients experienced grade four or grade five treatment-associated adverse events, indicating a favorable safety profile.

    “The updated OST-HER2 data presented at MIB Factor showed EFS data statistically significantly favoring OST-HER2-treated patients,” said Dr. Robert Petit, Chief Medical and Scientific Officer. “The favorable safety profile compared with the standard of care is also an important quality of life factor for this difficult-to-treat population.”

    Regulatory Tailwinds and PRV Potential

    Momentum with regulators has been steadily building. The U.S. Food and Drug Administration has scheduled an End of Phase 2 meeting with OS Therapies for August 27, 2025. There, the company will seek agreement to initiate a rolling Biologics License Application submission. Should that process move forward, OST-HER2 may become eligible for accelerated approval.

    OST-HER2 already holds several valuable FDA designations, including Orphan Drug, Fast Track, and Rare Pediatric Disease. If the therapy is approved before September 30, 2026, OSTX will be eligible to receive a Priority Review Voucher, which the company intends to sell. The last PRV transaction in June 2025 brought in $160 million.

    “We are making significant progress toward our primary objective of obtaining regulatory approval for OST-HER2 prior to the sunsetting of the PRV program,” said Chairman and CEO Paul Romness. “If successful, we expect to receive significant non-dilutive funding from the sale of the PRV, which we would then deploy in commercializing OST-HER2 and advancing other clinical candidates in our pipeline.”

    Global Strategy and Pipeline Expansion

    International efforts are also underway. OS Therapies has confirmed Scientific Advice Meetings with regulators in the United Kingdom and European Union, with plans to seek Conditional Marketing Authorization in both regions. In the UK, the company has secured access to the Clinical Practice Research Datalink, which could support real-world data submissions. It is also pursuing review through the European Medicines Agency’s centralized procedure.

    Beyond osteosarcoma, OSTX is preparing for data from a Phase 1 study of OST-504, a listeria-based immunotherapy for prostate cancer. All patients in that study have completed treatment, and results are expected later this year. The company is also advancing its tunable antibody drug conjugate platform, built around proprietary Si-Linker and Conditionally Active Payload technologies that aim to improve therapeutic precision.

    To support long-term growth, OS Therapies recently acquired several clinical and preclinical immunotherapy assets and was granted a new manufacturing patent tied to its listeria platform. These moves extend its intellectual property runway into 2040. The company has also formed two new subsidiaries, OS Animal Health and OS Drug Conjugates, to explore commercial applications in comparative oncology and targeted therapeutics.

    Final Word

    With statistically significant survival data, multiple regulatory designations, and a lead program approaching a key FDA meeting, OS Therapies (NYSE: OSTX) is positioned for a major inflection point. If OST-HER2 secures accelerated approval and qualifies for a Priority Review Voucher, the company could unlock meaningful non-dilutive funding. Between the late-stage momentum in osteosarcoma and a growing pipeline of immunotherapy and ADC programs, OSTX offers investors early exposure to a potential new leader in precision oncology.

    RazorPitch Inc. “RazorPitch” is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by O S Therapies Inc to assist in the production and distribution of content related to OSTX. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

     

  • Avenue Z Continues Award-Winning Momentum With New Honors for Marketing Innovation in AI Search

    Avenue Z Continues Award-Winning Momentum With New Honors for Marketing Innovation in AI Search

    Recognized across the industry, Avenue Z’s breakthrough work is driving record visibility and brand performance.

    MIAMI, FL – July 14, 2025 – Avenue Z, the tech-driven marketing and communications agency leading AI Optimization, today announced it has received two major honors for its industry-shaping innovation: the 2025 Miami Inno Fire Award and the 2025 Global Recognition Award, further cementing its status as the leader in brand visibility through AI search.

    These back-to-back awards recognize the company’s breakthrough in bringing to market a first-of-its-kind AI Optimization solution, driving measurable outcomes for hundreds of clients and reshaping how influence is earned in the generative AI era.

    “From day one, our mission has been to lead—not follow—in a new communications era where AI defines how people discover and trust brands,” said Jeffrey Herzog, Founder and CEO of Avenue Z. “Winning multiple awards for the same innovation confirms what we already know: AI search is the new front page, and we’re helping our clients own it.”

    The Global Recognition Award honors Avenue Z’s contribution to the future of marketing communications, citing the agency’s AI Visibility Index (AIVx) and proprietary Z-Score methodology as “industry-changing frameworks that redefine how brands are found, cited, and trusted across AI platforms.” Judges praised Avenue Z for its “measurable client results, paradigm-shifting innovation, and market-wide impact.”

    This builds on the momentum of Avenue Z’s Miami Inno Fire Award win from the South Florida Business Journal, which highlights its role in fueling the region’s innovation economy through AI-led marketing results.

    “These awards really reflect the velocity we’ve built around a single mission: to decode where influence is going next, and get our clients there first,” said Johnny Hughes, Chief Marketing Officer and Chair of the AI Council at Avenue Z. “We’re not reacting to AI, we’re shaping how brands use it to impact consumer discovery and decision-making.”

    In Q2 alone, Avenue Z expanded its Miami headquarters, opened a flagship Creator Studio, rolled out breakthrough AI research, and launched its AI Optimization solution, already generating over 500,000 conversions and $1 billion in eCommerce revenue across clients. 

    “Innovation is only as powerful as the outcomes it delivers,” said Whitney Hart, Chief Strategy Officer at Avenue Z. “What sets Avenue Z apart is our ability to bring award-winning ideas to life for our clients, boosting visibility, reputation, and growth across every channel that matters.”

    Avenue Z blends strategic communications, high-impact PR, performance media, and content development into an integrated solution. AI optimization is embedded across every discipline – from website development to media relations, strategic communications, and even paid media – ensuring clients have the digital assets needed to show up in traditional and AI search.

    “This award is a powerful validation of our strategic approach. We aren’t just placing stories, we are influencing ecosystems,” said Bristol Jones, VP and Managing Director of Avenue Z Miami. “At Avenue Z, we fuse narrative with data to architect visibility, credibility, and momentum across every channel that moves markets.”

    With multiple awards now recognizing its AI and marketing leadership, Avenue Z is on pace to become the definitive agency for brands navigating the AI era, and the results are proving it.

    For more information, visit AvenueZ.com or their media outlet, DrivingInfluence.com.

    About Avenue Z

    Avenue Z is a tech-driven marketing and communications agency leading AI optimization, driving influence across all channels – from ChatGPT to The Wall Street Journal to TikTok. With 30 years of leadership in search and digital marketing, we apply strategic communications, high-impact PR, performance media, and AI optimization to help companies build reputation and grow revenue through our proprietary, technology-driven approach. We are the agency for influence. AvenueZ.com

    ####

    Avenue Z

    +1 407-637-2833

    press@avenuez.com

     

  • SUN.io Launches SUN DAO to Enhance Decentralized Governance and Drive Ecosystem Innovation

    SUN.io Launches SUN DAO to Enhance Decentralized Governance and Drive Ecosystem Innovation

    Singapore,July 30, 2024, 12:00 PM – SUN.io, a leading DeFi platform built on the TRON blockchain, is thrilled to announce the launch of SUN DAO. This strategic initiative aims to enhance SUN.io’s decentralized governance and community autonomy. By expanding the real-world use cases of the SUN token, SUN DAO will support the development and long-term governance of the SUN.io protocol. At its core, SUN DAO relies on its protocol functions and the SUN token for security. These functions, which include community engagement, incentive measures, self-regulation, and policy management, are governed through on-chain proposals. The SUN token will be integral to this governance process, integrating and digitizing various forms of capital, such as monetary and human resources, and encouraging active participation from community members in governance and proposals. With the introduction of SUN DAO, SUN.io will transition to a fully decentralized governance model, empowering community members to participate actively in the platform’s voting and decision-making processes. Industry experts believe that SUN DAO will redefine decentralized governance, setting new benchmarks in the DeFi ecosystem for transparency, fairness, and innovation. Explore New Horizons in Decentralized Governance with SUN DAO SUN DAO leverages innovative incentive mechanisms and a tiered governance structure to establish a future-proof governance model, ensuring the long-term success of the SUN.io protocol. This approach is designed to drive continuous growth and improvement, maintaining the platform’s relevance and effectiveness for decades to come. Under the current system, SUN holders can collectively manage the protocol and vote on proposals by converting their tokens into veSUN. Community members with a specified amount of veSUN holdings can submit proposals. For a proposal to be executed, it must receive a minimum number of yes votes and have more yes votes than no votes. This mechanism ensures efficient governance without third-party intervention, allowing the protocol to operate, manage, and develop autonomously according to predefined rules, thereby maximizing efficiency. The SUN token plays a crucial role in this process, digitizing and tokenizing all organizational elements, integrating both monetary and human capital, and significantly enhancing overall efficiency. According to the SUN.io team, the SUN token economy is designed to foster the healthy development and growth of the SUN.io ecosystem in the long term, ultimately benefiting all stakeholders under a robust protocol. SUN.io has introduced economic incentives based on the trust established by SUN DAO, including mutual trust among SUN token holders, the market, liquidity providers, and integrators. These liquidity-based governance approaches aim to sustain active participation in the voting process and expand the pools as the ecosystem grows and attracts more participants. Fostering Innovation on SUN.io to Unlock Diverse veSUN Use Cases The official launch of SUN DAO will significantly expand the use cases of its vote escrow mechanism, veSUN, encouraging greater participation from community users and driving further innovation and development across the SUN.io ecosystem. Users can lock up SUN tokens to receive veSUN, the voting certificate that grants them a voice in platform governance. Those holding a certain amount of veSUN can submit governance proposals to support new markets, add functionalities to the protocol, and more. Other veSUN holders can vote on the proposals while enjoying benefits such as liquidity mining boosts, votes to determine the weights of liquidity pools and 50% of transaction fees in stablecoin pools. Industry experts believe that adopting autonomous governance will revitalize the SUN.io ecosystem. By decentralizing community governance, users gain greater flexibility in resource allocation and can contribute valuable insights for development and improvement. This approach unites community efforts to drive product iteration and fosters a stronger sense of belonging and responsibility among members. By introducing a decentralized, multi-tiered governance framework powered by an incentivized system, SUN DAO motivates community members to propose innovative ideas and solutions, ensuring active participation in the voting process. By attracting new users and investments, SUN DAO fosters growth and innovation within the platform and the broader DeFi sector. As a crucial component of the TRON ecosystem, SUN.io’s implementation of the DAO model is set to attract a broader community of users and developers, supporting TRON in maintaining a healthy, self-reinforcing DeFi ecosystem. SUN.io, the pioneering integrated platform on the TRON network, offers a comprehensive suite of decentralized financial services, including stablecoin swaps, liquidity mining, and the conversion of Dominica’s authorized digital currency while enabling self-governance. As of July 2024, SUN.io amassed a total value locked (TVL) of $431 million. The establishment of SUN DAO will further solidify its leading role in the DeFi ecosystem by extending premium decentralized financial services globally, fostering sustained innovation and growth in the industry. About SUN DAO SUN DAO is a platform aimed at achieving genuine community autonomy and open collaboration through blockchain technology and smart contracts. As a decentralized autonomous organization (DAO), we provide a fair, transparent, and efficient decision-making framework for community members, enabling everyone to equally participate in project development and governance. About SUN.io SUN.io is the first decentralized autonomous platform on the TRON network that integrates stablecoin and comprehensive token exchange while supporting liquidity mining. It aims to provide optimal trading liquidity and asset returns for the TRON ecosystem. Users can stake SUN to obtain veSUN, allowing them to enjoy multiple platform benefits. Media Contact Karina.Wang marketing@sun.io Contact Details Karina.Wang marketing@sun.io